News

  • 2021 FDA New Drug Approvals 1Q-3Q

    Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA's Center for Drug Evaluation and Research (CDER) supports the pharmaceutical industry at every step of the process. With its understanding of ...
    Read more
  • Recent developments of Sugammadex Sodium in the wake period of anesthesia

    Recent developments of Sugammadex Sodium in the wake period of anesthesia

    Sugammadex Sodium is a novel antagonist of selective non-depolarizing muscle relaxants (myorelaxants), which was first reported in humans in 2005 and has since been used clinically in Europe, the United States and Japan. Compared with traditional anticholinesterase drugs...
    Read more
  • Which tumors are thalidomide effective in treating!

    Which tumors are thalidomide effective in treating!

    Thalidomide is effective in treating these tumors! 1. In which solid tumors can thalidomide be used. 1.1. lung cancer. 1.2. Prostate cancer. 1.3. nodal rectal cancer. 1.4. hepatocellular carcinoma. 1.5. Gastric cancer. ...
    Read more
  • Tofacitinib Citrate

    Tofacitinib Citrate

    Tofacitinib citrate is a prescription drug (trade name Xeljanz) originally developed by Pfizer for a class of oral Janus kinase (JAK) inhibitors. It can selectively inhibit JAK kinase, block JAK/STAT pathways, and thereby inhibit cell signal transduction and Related gene expression and activatio...
    Read more
  • Apixaban and Rivaroxaban

    Apixaban and Rivaroxaban

    In recent years, the sales of apixaban have grown rapidly, and the global market has already surpassed rivaroxaban. Because Eliquis (apixaban) has an advantage over warfarin in preventing stroke and bleeding, and Xarelto ( Rivaroxaban) only showed non-inferiority. In addition, Apixaban does not...
    Read more
  • Guangzhou API exhibition in 2021

    Guangzhou API exhibition in 2021

    The 86th China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Fair (API China for short) Organizer: Reed Sinopharm Exhibition Co., Ltd. Exhibition time: May 26-28, 2021 Venue: China Import and Export Fair Complex (Guangzhou) Exhibition scale: 60,000 square meters Ex...
    Read more
  • Obeticholic acid

    On June 29, Intercept Pharmaceuticals announced that it has received a complete new drug application from the US FDA regarding its FXR agonist obeticholic acid (OCA) for fibrosis caused by non-alcoholic steatohepatitis (NASH) Response letter (CRL). The FDA stated in the CRL that based on the data...
    Read more
  • Remdesivir

    On October 22, Eastern time, the US FDA officially approved Gilead’s antiviral Veklury (remdesivir) for use in adults 12 years and older and weighing at least 40 kg in need of hospitalization and COVID-19 treatment. According to the FDA, Veklury is currently the only FDA-approved COVID-19 t...
    Read more
  • Approval notice for Rosuvastatin Calcium

    Recently, Nantong Chanyoo have made another milestone in the history! With the efforts for more than one year, the first KDMF of Chanyoo has got approved by MFDS. As the biggest manufacturer of Rosuvastatin Calcium in China, we wish to open a new chapter in Korea market. And more products would b...
    Read more
  • Registration Certificate (Rosuvastatin)

    Registration Certificate (Rosuvastatin)

    Read more
  • The difference between Ticagrelor and Clopidogrel

    Clopidogrel and Ticagrelor are P2Y12 receptor antagonists that inhibit plateboard adenosine diphosphate (ADP) by selectively inhibiting the binding of adenosine diphosphate (ADP) to its plateboard P2Y12 receptor and the activity of the secondary ADP-mediated glycoprotein GPII.b/III.a complex. Bot...
    Read more
  • The difference between atorvastatin calcium tablets and rosuvastatin calcium tablets

    Atorvastatin calcium tablets and rosuvastatin calcium tablets are both statin lipid-lowering drugs, and both belong to relatively powerful statin drugs. The specific differences are as follows: 1. From the perspective of pharmacodynamics, if the dose is the same, the lipid-lowering effect of rosu...
    Read more
12 Next > >> Page 1 / 2